Technology News and Research

RSS

Stallergenes chooses Magic Software's iBOLT integration platform

Magic Software Enterprises Ltd., a global provider of mobile and cloud-enabled application and business integration platforms, announced today that Stallergenes, a biopharmaceutical company and world leader in the treatment of severe allergic respiratory illnesses, has chosen Magic Software's iBOLT integration platform to integrate its various purchasing systems with its SAP ERP.

17 Jan 2012

Traditional autopsy is still the gold standard in determining cause of death

TV crime shows like Bones and CSI are quick to explain each death by showing highly detailed scans and video images of victims' insides. Traditional autopsies, if shown at all, are at best in supporting roles to the high-tech equipment, and usually gloss over the sometimes physically grueling tasks of sawing through skin and bone.

17 Jan 2012

Hormone that burns energy discovered

Boston scientists have found a hormone that is secreted by muscles during exercise and boosts the amount of energy the body burns. This hormone – irisin – could be the first step in development of new drugs for obesity, diabetes, and other diseases feel researchers. A Boston startup company, Ember Therapeutics, has already licensed the technology and is working to develop a form of the hormone that could be used as a drug that would mimic some of the benefits of exercise.

16 Jan 2012

ForSight VISION4 to receive first milestone payment for Lucentis drug delivery device

Genentech, a member of the Roche Group, today announced it will make its first milestone payment to ForSight VISION4, Inc. as part of an exclusive license agreement to develop the company's investigational drug delivery device, designed to provide sustained delivery of Lucentis (ranibizumab).

13 Jan 2012

S.C. GOP primary puts spotlight on Romney abortion stance

Nine days before the South Carolina primary, Mitt Romney has 'picked up his pro-life rhetoric' as Newt Gingrich goes on the attack.

13 Jan 2012

Agilux implements Thermo Watson LIMS for bioanalytical services

Agilux Laboratories, a provider of pharmaceutical and biotech services, today announced that it has completed the validation and implementation of the Thermo Watson Laboratory Information Management System (LIMS) for the company's bioanalytical services.

13 Jan 2012

U.S. Army working to bring virtual health care to Albanian hospitals

The U.S. Army in a news article on its website reports on how it is working to "bring virtual health care to Albanian hospitals" through a telemedicine program that "aims to link different levels of health care to ensure a better functioning and sustainable system."

13 Jan 2012

IBM's non-contact, microfluidic, silicon probe minimizes patient discomfort

IBM scientists have developed a flexible, non-contact microfluidic probe made from silicon that can aid researchers and pathologists to investigate critical tissue samples accurately for drug discovery and disease diagnostics.

13 Jan 2012

CHUMS project to measure outcomes of NHS care in children with neurodisabilites

An exciting new study that will help put children with neurodisabilites at the centre of evaluating their own care has received almost a quarter of a million pounds (£250,00) in funding. The CHildren's oUtcome Measurement Study (CHUMS) will assess how to capture the views and experiences of children with neurodisability and their families in order to measure the outcomes of the NHS care they receive.

13 Jan 2012

Scientists identify chemical signals that promote aggregation in roundworms

Scientists have long seen evidence of social behavior among many species of animals, both on the earth and in the sea. Dolphins frolic together, lions live in packs, and hornets construct nests that can house a large number of the insects. And, right under our feet, it appears that nematodes-also known as roundworms-are having their own little gatherings in the soil. Until recently, it was unknown how the worms communicate to one another when it's time to come together.

13 Jan 2012

Smart injectable nanotherapeutics could improve treatment for Type I diabetes

A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has developed "smart" injectable nanotherapeutics that can be programmed to selectively deliver drugs to the cells of the pancreas. Although this nanotechnology will need significant additional testing and development before being ready for clinical use, it could potentially improve treatment for Type I diabetes by increasing therapeutic efficacy and reducing side effects.

13 Jan 2012

Researchers discover previously unknown effect of opioids

A team of researchers at the MedUni Vienna's Department of Neurophysiology has discovered a previously unknown effect of opioids: the study, which has now been published in the highly respected magazine "Science" and was led by Ruth Drdla-Schutting and Jürgen Sandkühler, shows that opioids not only temporarily relieve pain, but at the right dose can also erase memory traces of pain in the spinal cord and therefore eliminate a key cause of chronic pain.

13 Jan 2012

Heart bracelet system could prevent cases of sports-related sudden death

The use of heart bracelets connected via ICT to a system of tracking and monitoring could prevent cases of sudden death in sports activities.

13 Jan 2012

CrystalGenomics raises KRW 3 billion in private placement

CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund.

13 Jan 2012

New lab test quickly identifies bacterium responsible for staph infections

Researchers from the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC) have developed a new laboratory test that can rapidly identify the bacterium responsible for staph infections. This new test takes advantage of unique isotopic labeling combined with specific bacteriophage amplification to rapidly identify Staphylococcus aureus.

13 Jan 2012

TAMEST honors UT Southwestern scientist with Edith and Peter O'Donnell Award

Dr. Philipp Scherer, director of the Touchstone Center for Diabetes Research at UT Southwestern Medical Center, was recognized today as a rising star in Texas research by The Academy of Medicine, Engineering and Science of Texas.

13 Jan 2012

Ocular drug delivery: DSM awarded membership in PANOPTES EU Funded Consortium

DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium’s goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM’s polyesteramide (PEA) biomaterials as a superior drug delivery technology.

12 Jan 2012

Study shows how new electronic medication management system reduces drug administration errors

Errors in administration of medication are a serious problem in long-term residential care. New research completed by the University of Warwick and the University of the West of England, Bristol (UWE) shows how a new electronic medication management system developed in the UK specifically for use in residential and nursing homes, has been shown to significantly reduce drug administration errors.

12 Jan 2012

CDC, NIST develop two new SRMs for measurements of toxic environmental chemicals

The National Institute of Standards and Technology (NIST), in collaboration with the Centers for Disease Control and Prevention (CDC), has developed two new Standard Reference Materials (SRMs) for measurements of human exposure to environmental toxins.

12 Jan 2012

New NIST clinical SRM can help in accurate CMV detection and treatment

A new clinical Standard Reference Material (SRM) from the National Institute of Standards and Technology (NIST) will help health care professionals more accurately diagnose and treat cytomegalovirus (CMV), a common pathogen that is particularly dangerous for infants and persons with weakened immune systems.

12 Jan 2012